TEVA PHARMACEUTICALS USA, INC.

Lobbying client · New Jersey · filed 2025 to 2026

Pharmaceutical company

$160,000 Reported spend

6 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (68590), not by name.

Firms hired 1

TALLEY STRATEGIES LLC $160,000 6 filings

Reported by year 2 years

2026 $60,000 3 filings
2025 $100,000 3 filings

Issues lobbied 2

Health Issues 3
Pharmacy 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

Commerce, Dept of (DOC) 2
HOUSE OF REPRESENTATIVES 2
SENATE 2

Recent filings 6 total

3TY

TALLEY STRATEGIES LLC

3rd Quarter (July 1 - Sep 30) 2026 · posted Sep 4, 2026

View → Q2Y

TALLEY STRATEGIES LLC

2nd Quarter (Apr 1 - June 30) 2026 · posted Jul 20, 2026

View → Q1Y

TALLEY STRATEGIES LLC

1st Quarter (Jan 1 - Mar 31) 2026 · $60,000 income · posted Apr 21, 2026

View → Q4

TALLEY STRATEGIES LLC

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $60,000 income · posted Jan 20, 2026

View → Q3

TALLEY STRATEGIES LLC

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $40,000 income · posted Oct 20, 2025

View → RR

TALLEY STRATEGIES LLC

3rd Quarter (July 1 - Sep 30) 2025 · posted Sep 8, 2025

View →

Foreign entities disclosed 1

TEVA PHARMACEUTICAL INDUSTRIES LTD. Israel named on 1 filing · highest disclosed ownership 100% · largest disclosed contribution $0

Section 7 of the LD-2: a foreign company or government that owns part of the client, pays toward the lobbying, or benefits from it. Figures are the highest single disclosure across these filings, not a sum: the same stake is re-disclosed each quarter.

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.